Berberine upregulated miR-340-5p and suppressed inflammation in myocardial ischemia and inhibited HMGB1/TLR4/NF-κB signaling in cardiomyocyte apoptosis and cancer-related myocardial impairment (45, 48). The gene discussed is HMGB1; the disease is cancer.